These effects often subside as the body adjusts to the medication
Searches for Mounjaro and Zepbound skyrocketed between 2024 and 2025, with over 1.5 million Brits now taking a weight-loss drug (a share that has nearly doubled in this period)
Reframing newness to communicate the track record Patients sometimes equate new drug with unknown risk. For many individuals, hesitation toward GLP-1RA therapy stems from broader mistrust in the healthcare system, previous negative experiences with medications, or a preference for natural or holistic approaches
Temporary relief becomes common when one or more of these issues remains unaddressed: Blood flow remains limited , which slows repair Inflammation remains reactive , which disrupts collagen rebuilding Collagen remodeling remains incomplete , which leaves the tissue weak Stability remains impaired , which keeps load distribution dysfunctional This is where peptide protocols can be useful
Want to see if Semaglutide is right for you
Food choices can help with mild discomfort, but they do not replace medical advice